Your browser doesn't support javascript.
loading
Why Levosimendan Improves the Clinical Condition of Patients With Advanced Heart Failure: A Holistic Approach.
Apostolo, Anna; Vignati, Carlo; Della Rocca, Michele; De Martino, Fabiana; Berna, Giovanni; Campodonico, Jeness; Contini, Mauro; Muratori, Manuela; Palermo, Pietro; Mapelli, Massimo; Alimento, Marina; Pezzuto, Beatrice; Agostoni, Piergiuseppe.
Afiliação
  • Apostolo A; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Vignati C; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Della Rocca M; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • De Martino F; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Berna G; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Campodonico J; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Contini M; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Muratori M; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Palermo P; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Mapelli M; Centro Cardiologico Monzino, IRCCS, Milan, Italy; Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Alimento M; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Pezzuto B; Centro Cardiologico Monzino, IRCCS, Milan, Italy.
  • Agostoni P; Centro Cardiologico Monzino, IRCCS, Milan, Italy; Cardiovascular Section, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. Electronic address: piergiuseppe.agostoni@ccfm.it.
J Card Fail ; 28(3): 509-514, 2022 03.
Article em En | MEDLINE | ID: mdl-34763079
ABSTRACT

BACKGROUND:

In advanced heart failure (HF), levosimendan increases peak oxygen uptake (VO2). We investigated whether peak VO2 increase is linked to cardiovascular, respiratory, or muscular performance changes. METHODS AND

RESULTS:

Twenty patients hospitalized for advanced HF underwent, before and shortly after levosimendan infusion, 2 different cardiopulmonary exercise tests (a) a personalized ramp protocol with repeated arterial blood gas analysis and standard spirometry including alveolar-capillary gas diffusion measurements at rest and at peak exercise, and (b) a step incremental workload cardiopulmonary exercise testing with continuous near-infrared spectroscopy analysis and cardiac output assessment by bioelectrical impedance analysis.Levosimendan significantly decreased natriuretic peptides, improved peak VO2 (11.3 [interquartile range 10.1-12.8] to 12.6 [10.2-14.4] mL/kg/min, P < .01) and decreased minute ventilation to carbon dioxide production relationship slope (47.7 ± 10.7 to 43.4 ± 8.1, P < .01). In parallel, spirometry showed only a minor increase in forced expiratory volume, whereas the peak exercise dead space ventilation was unchanged. However, during exercise, a smaller edema formation was observed after levosimendan infusion, as inferable from the changes in diffusion components, that is, the membrane diffusion and capillary volume. The end-tidal pressure of CO2 during the isocapnic buffering period increased after levosimendan (from 28 ± 3 mm Hg to 31 ± 2 mm Hg, P < .01). During exercise, cardiac output increased in parallel with VO2. After levosimendan, the total and oxygenated tissue hemoglobin, but not deoxygenated hemoglobin, increased in all exercise phases.

CONCLUSIONS:

In advanced HF, levosimendan increases peak VO2, decreases the formation of exercise-induced lung edema, increases ventilation efficiency owing to a decrease of reflex hyperventilation, and increases cardiac output and muscular oxygen delivery and extraction.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article